Exchange transfusion for severe malaria: evidence base and literature review
- PMID: 23800940
- PMCID: PMC10984079
- DOI: 10.1093/cid/cit429
Exchange transfusion for severe malaria: evidence base and literature review
Abstract
Background: Exchange transfusion (ET) has biologic plausibility as an adjunct to antimalarial drugs in treating severe malaria and has been used for decades despite limited evidence of its efficacy in improving survival. We examined the efficacy of ET as an adjunct treatment for severe malaria using US surveillance data and reviewed the literature to update recommendations.
Methods: Patients with severe malaria reported to the US national malaria surveillance system during 1985-2010 were matched, and survival outcomes were compared between patients receiving and not receiving ET. The literature review used search terms "severe malaria" and "exchange transfusion." Case reports and series, observational and case-control studies, and meta-analysis were included.
Results: One hundred one patients receiving ET were matched to 314 patients not receiving ET. There was no statistically significant association between ET and survival outcome (odds ratio, 0.84; 95% confidence interval, .44-1.60). We found 87 articles, mostly case reports or series, showing successful use of ET, likely reporting bias. There were 12 comparative studies, most of which were retrospective cohort studies, underpowered with no significant differences in survival. A previously published meta-analysis of 8 comparative studies found no significant survival differences. Adverse events were rarely reported but included acute respiratory distress syndrome, ventricular fibrillation, and hypotension.
Conclusions: Despite rapid parasite clearance times resulting from ET, there is no evidence for efficacy of ET as adjunctive therapy in severe malaria. Adjunct ET cannot be recommended. When rapidly acting antimalarials, specifically artemisinins, become more widely available, the biologic plausibility argument for ET will become less relevant.
Keywords: exchange transfusion; malaria treatment; severe malaria.
Conflict of interest statement
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
Comment in
-
American society for apheresis guidelines support use of red cell exchange transfusion for severe malaria with high parasitemia.Clin Infect Dis. 2014 Jan;58(2):302-3. doi: 10.1093/cid/cit662. Epub 2013 Oct 2. Clin Infect Dis. 2014. PMID: 24092801 No abstract available.
References
-
- Gyr K, Speck B, Ritz R, Cornu P, Buckner CD. Cerebral tropical malaria with blackwater fever. A current diagnostic and therapeutic problem [in German]. Schweiz Med Wochenschr 1974; 104:1628–30. - PubMed
-
- World Health Organization, Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(suppl 1):S1–90. - PubMed
-
- Chuncharunee S, Jootar JS, Leelasiri A, et al. Levels of serum tumor necrosis factor alpha in relation to clinical involvement and treatment among Thai adults with Plasmodium falciparum malaria. J Med Assoc Thai 1997; 80(suppl 1):S72–5. - PubMed
-
- Valbonesi M, Bruni R. Clinical application of therapeutic erythrocytapheresis (TEA). Transfus Sci 2000; 22:183–94. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources